Entero Healthcare Solutions Limited IPO
MainboardPharmacy Retail
Listed On: Feb 16, 2024 at ₹ 1228.70(NSE)
₹ 13838 /11 Shares
Check Allotment09 Feb, 2024
Open Date13 Feb, 2024
Close Date14 Feb, 2024
Allotment Date16 Feb, 2024
Listing DatePrice Summary
Last Closing
976.00 (-22.42%)52 Week High
1,563.9052 Week Low
968.80Last Update
18-Dec-2025 3:30 PMEntero Healthcare Solutions Limited IPO Issue Details
- Issue Price ₹1195-1258 per equity share
- Face Value ₹10 Per Equity Share
- Total Issue Size 1,27,18,600 shares(aggregating up to ₹1600 crore)
- Fresh Share 79,49,125 shares(aggregating up to ₹1000 crore)
- Offer For Sale 47,69,475 shares(aggregating up to ₹600 crore)
- Listing at BSE, NSE
- List Price 1228.70(NSE)
- Listing Date 2024-02-16
-
Lead Manager
ICICI Securities Limited
Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd)
Jefferies India Private Limited
Jm Financial Limited
SBI Capital Markets Limited - Registrar Link Intime India Private Ltd
Market Lot Size
Investors can bid for a minimum of 11 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 11 | ₹13,838 |
| Retail(max) | 14 | 154 | ₹1,93,732 |
| SHNI(min) | 15 | 165 | ₹2,07,570 |
| SHNI(max) | 72 | 792 | ₹9,96,336 |
| BHNI(min) | 73 | 803 | ₹10,10,174 |
Entero Healthcare Solutions Limited IPO Reservation
Entero Healthcare Solutions Limited IPO offers total 12,844,853 shares. Out of which 3,808,069 (29.65%) allocated to QIB, 1,960,609 (15.26%) allocated to NII,1,307,073 (10.18%) allocated to RII, 74,349 (0.58%) allocated to employees and 5,694,753 (44.33%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 5,694,753 (44.33%) | |
| QIB Shares Offered | 3,808,069 (29.65%) | |
| NII (HNI) Shares Offered | 1,960,609 (15.26%) | |
| bNII > ₹10L | 1,307,072 (10.18%) | |
| sNII < ₹10L | 653,537 (5.09%) | |
| Retail Shares Offered | 1,307,073 (10.18%) | |
| Employee Shares Offered | 74,349 (0.58%) | |
| Total Shares Offered | 12,844,853 (100%) |
Entero Healthcare Solutions Limited IPO Details
Entero Healthcare Solutions Limited IPO is a book-built issue of ₹1600 crores, The total issue size is ₹1600 crores. The IPO of Entero Healthcare Solutions Limited is priced at ₹1195-1258 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Feb 9, 2024 and ends on Feb 13, 2024. The allotment for Entero Healthcare Solutions Limited IPO will be finalized on Feb 14, 2024. Entero Healthcare Solutions Limited IPO will be listed on BSE, NSE, with a tentative listing date fixed as Feb 16, 2024. The company shall list its equity shares on the BSE, NSE. Link Intime India Private Ltd is the registrar of the issue.
Retail investors can bid for a minimum of 11 shares, extendable to 13,838. S-HNIs will be able to bid for 165 shares at ₹2,07,570, while B-HNIs can also apply for a bid of 803 shares at ₹10,10,174. The book-running lead manager for the IPO is/are ICICI Securities Limited, Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd), Jefferies India Private Limited, Jm Financial Limited, SBI Capital Markets Limited.
The total issue ₹1600 crore, comprising a fresh issue of 79,49,125 shares ₹1000 crore and having Offer for Sale (OFS) of 47,69,475 shares to mop up ₹600 crore.
The Entero Healthcare Solutions Limited IPO sets its price band at 1195-1258 for each share. A single application for Entero Healthcare Solutions Limited IPO must contain at least 11 shares. Sentiment investors need to invest a minimum of 11 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹13,838 In order to participate in the sNII, investors must purchase at least 15 lots of 165 shares for ₹2,07,570, while the bNII requires 73 lots of 803 shares for an investment of ₹10,10,174.
Read More
Entero Healthcare Solutions Limited IPO Subscription Analysis And Details
| As on | QIB | NII
bNII sNII |
Retail | Employee | Total |
|---|---|---|---|---|---|
| Shares Offered / Reserved | 37,96,502 |
18,98,251
12,65,501 6,32,750 |
18,98,251 | 70,625 | 76,63,629 |
|
Day 1
09-02-24 05:00 PM
|
0.00 x |
0.04
0.03 x 0.08 x |
0.32 x | 0.36 x | 0.09 x |
|
Day 2
12-02-24 05:00 PM
|
0.00 x |
0.09
0.05 x 0.17 x |
0.88 x | 0.77 x | 0.19 x |
|
Day 3
13-02-24 05:00 PM
|
2.28 x |
0.22
0.16 x 0.33 x |
1.33 x | 1.25 x | 1.53 x |
Entero Healthcare Solutions Limited Valuations
Entero Healthcare Solutions Limited Company Financials
| 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | |
|---|---|---|---|
| Assets | 1,308.73 | 1,125.98 | 833.79 |
| Revenue | 3,305.72 | 2,526.55 | 1,783.67 |
| Profit After Tax | -11.10 | -29.44 | -15.35 |
| Net Worth | 597.66 | 563.22 | 487.06 |
| Total Borrowing | 373.52 | 285.03 | 141.70 |
About Entero Healthcare Solutions Limited Company
Entero Healthcare Solutions Limited is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.
During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. Additionally, they also served over 1,600, 2,500, and 3,400 hospital customers during the same period.
Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.
The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.
As of 31st March, 2023, the company employs a total of 3014 people in various departments.
Entero Healthcare Solutions Limited - Promoter(s)
Prabhat Agrawal
Prem Sethi
OrbiMed Asia III Mauritius Limited
Pre Issue Share Holding : 77.11%
Post Issue Share Holding : N/A%
Entero Healthcare Solutions Limited IPO - Issue Objectives
Repayment/prepayment, in full or part, of certain borrowings availed of by the company and our Subsidiaries.
Funding the long term working capital requirements.
Pursuing inorganic growth initiatives through acquisitions.
General corporate purposes.
Entero Healthcare Solutions Limited IPO - Anchor Investors
Entero Healthcare Solutions raises Rs 716 crore from anchor investors ahead of IPO.
Global marquee investors Smallcap World Fund Inc, Government of Singapore, Monetary Authority of Singapore, Carmignac Portfolio, CLSA Global, Societe Generale, Morgan Stanley, Goldman Sachs, and Copthall Mauritius Investment participated in the anchor book.
Among others, Amundi Funds, Jupiter India Fund, SBI General Insurance Company, Private Client Emerging Markets Portfolio, Magna Umbrella Fund, Bajaj Allianz Life Insurance, TT Emerging Markets Unconstrained Fund, and Allianz Global Investors Fund also invested in the company through anchor book.
Entero Healthcare Solutions Limited IPO - Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Entero Healthcare Solutions Limited | -3.43 | -3.43 | 174.21 | N/A | -1.86 | N/A | Consolidated |
| Medplus Health Services Limited | 4.17 | 4.17 | 124.93 | 177.21 | 3.36 | 5.91 | Consolidated |
Notes:
- P/E Ratio has been computed based on the closing market price of equity shares on NSE on August 28, 2023, divided by the Diluted EPS.
- Return on Net Worth (RoNW) (%) = Net Profit / (Loss) after tax/ Net worth (Total Equity) at the end of the year.
- NAV is computed as the closing net worth (excluding minority interest) divided by the closing outstanding number of equity shares.
- Net asset value per share represents net worth as of the end of the relevant year divided by the number of equity share post conversion outstanding at the end of the respective year.
Contact Details
Entero Healthcare Solutions Limited
Plot No. I-35, Building - B, Industrial Area Phase - I, 13/7 Mathura Road, Faridabad 121 003
+91 22-69019100
Registrar Contact Details
Entero Healthcare Solutions Limited IPO - FAQs
Ans. Entero Healthcare Solutions Limited IPO is a Mainboard IPO. The issue is priced at ₹1195-1258 per equity share. The minimum order quantity is 11 Shares. The IPO opens on Feb 9, 2024, and closes on Feb 13, 2024. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Entero Healthcare Solutions Limited IPO opens on Feb 9, 2024 and closes on Feb 13, 2024.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Entero Healthcare Solutions Limited IPO is Total ₹1600 Cr : #Fresh Issue : 7,949,125 shares(aggregating up to ₹1000.00 Cr) + #OFS : 4,769,475 shares of ₹10(aggregating up to ₹600.00 Cr).
Ans. The Entero Healthcare Solutions Limited IPO price band is set between ₹1195-1258 per equity share.
Ans. To apply for Entero Healthcare Solutions Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Entero Healthcare Solutions Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Entero Healthcare Solutions Limited IPO is Feb 14, 2024.
Ans. The Entero Healthcare Solutions Limited IPO will be listed on Feb 16, 2024.
Ans. Follow the steps to check the Entero Healthcare Solutions Limited IPO allotment status online.
